Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | MMP2 | P08253 | 1/20 | 0.52 |
| ▸ | HMGB1 | P09429 | 2/20 | 0.49 |
| ▸ | HNF4A | P41235 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1272896 | 0.83 | ALDH1A1 (0.55) | ALBALDH1A1KDM4EHSD17B10HPGD | |
| SCHEMBL110532 | 0.82 | ALDH1A1 (0.70) | ALBALDH1A1KDM4EHSD17B10HPGD | |
| SCHEMBL8436637 | 0.82 | HNF4A (0.55) | ALBALDH1A1KDM4EHSD17B10HPGD | |
| SCHEMBL3428071 | 0.81 | ALDH1A1 (0.64) | ALDH1A1KDM4EHSD17B10HPGDHMGB1 | |
| SCHEMBL1582462 | 0.81 | HNF4A (0.63) | ALBALDH1A1KDM4EHSD17B10HPGD | |
| Methane SCHEMBL28154128 | 0.80 | ALDH1A1 (0.67) | ALBALDH1A1KDM4EHSD17B10HPGD | |
| Hydrochloric Acid SCHEMBL28210457 | 0.80 | ALDH1A1 (0.67) | ALBALDH1A1KDM4EHSD17B10HPGD | |
| SCHEMBL28094410 | 0.80 | ALDH1A1 (0.67) | ALBALDH1A1KDM4EHSD17B10HPGD | |
| SCHEMBL7165288 | 0.80 | ALDH1A1 (0.52) | ALBALDH1A1KDM4EHSD17B10HPGD | |
| SCHEMBL2763225 | 0.80 | ALDH1A1 (0.57) | ALBALDH1A1KDM4EHSD17B10HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7572907-B2 | Methods and compounds for polynucleotide synthesis | AGILENT TECHNOLOGIES, INC. (US) | 2009-08-11 | — | — | US | disclosed |
| EP-1717242-A1 | Polynucleotide synthesis | Agilent Technologies, Inc. (US) | 2006-11-02 | — | — | EP | disclosed |
| US-20060247430-A1 | Methods and compounds for polynucleotide synthesis | AGILENT TECHNOLOGIES, INC. | 2006-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060247430-A1 | Methods and compounds for polynucleotide synthesis | POLN, POLRMT, POLM | ALB 3525/4885ALDH1A1 3888/4885KDM4E 4662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.